J&J Recalls 57K Bottles Of Topamax Over Odor

Law360, New York (April 14, 2011, 11:52 AM EDT) -- Johnson & Johnson unit Ortho-McNeil-Janssen Pharmaceuticals Inc. on Thursday recalled 57,000 bottles of Topamax due to an uncharacteristic odor, marking the pharmaceutical giant's latest trouble with the epilepsy drug.

J&J said the foul odor was caused by a chemical preservative called 2,4,6-tribromoanisole, which is sometimes applied to the wood in pallets used to ship products. No serious injuries have been reported, but J&J said the chemical, though not toxic, could cause temporary gastrointestinal symptoms in a small number of patients.

The recall did not appear related...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.